Siepe Christoph J, Heider Franziska, Wiechert Karsten, Hitzl Wolfgang, Ishak Basem, Mayer Michael H
Schön Klinik Munich Harlaching, Spine Center, Academic Teaching Hospital of the Paracelsus Medical University Salzburg (AU), Harlachinger Str. 51, D-81547 Munich, Germany.
Schön Klinik Munich Harlaching, Spine Center, Academic Teaching Hospital of the Paracelsus Medical University Salzburg (AU), Harlachinger Str. 51, D-81547 Munich, Germany.
Spine J. 2014 Aug 1;14(8):1417-31. doi: 10.1016/j.spinee.2013.08.028. Epub 2014 Jan 18.
The role of fusion of lumbar motion segments for the treatment of intractable low back pain (LBP) from degenerative disc disease (DDD) without deformities or instabilities remains controversially debated. Total lumbar disc replacement (TDR) has been used as an alternative in a highly selected patient cohort. However, the amount of long-term follow-up (FU) data on TDR is limited. In the United States, insurers have refused to reimburse surgeons for TDRs for fear of delayed complications, revisions, and unknown secondary costs, leading to a drastic decline in TDR numbers.
To assess the mid- and long-term clinical efficacy as well as patient safety of TDR in terms of perioperative complication and reoperation rates.
STUDY DESIGN/SETTING: Prospective, single-center clinical investigation of TDR with ProDisc II (Synthes, Paoli, PA, USA) for the treatment of LBP from lumbar DDD that has proven unresponsive to conservative therapy.
Patients with a minimum of 5-year FU after TDR, performed for the treatment of intractable and predominant (≥80%) axial LBP resulting from DDD without any deformities or instabilities.
Visual analog scale (VAS), Oswestry Disability Index (ODI), and patient satisfaction rates (three-scale outcome rating); complication and reoperation rates as well as elapsed time until revision surgery; patient's professional activity/employment status.
Clinical outcome scores were acquired within the framework of an ongoing prospective clinical trial. Patients were examined preoperatively, 3, 6, and 12 months postoperatively, annually from then onward. The data acquisition was performed by members of the clinic's spine unit including medical staff, research assistants, and research nurses who were not involved in the process of pre- or postoperative decision-making.
The initial cohort consisted of 201 patients; 181 patients were available for final FU, resembling a 90.0% FU rate after a mean FU of 7.4 years (range 5.0-10.8 years). The overall results revealed a highly significant improvement from baseline VAS and ODI levels at all postoperative FU stages (p<.0001). VAS scores demonstrated a slight (from VAS 2.6 to 3.3) but statistically significant deterioration from 48 months onward (p<.05). Patient satisfaction rates remained stable throughout the entire postoperative course, with 63.6% of patients reporting a highly satisfactory or a satisfactory (22.7%) outcome, whereas 13.7% of patients were not satisfied. The overall complication rate was 14.4% (N=26/181). The incidence of revision surgeries for general and/or device-related complications was 7.2% (N=13/181). Two-level TDRs demonstrated a significant improvement of VAS and ODI scores in comparison to baseline levels (p<.05). Nevertheless, the results were significantly inferior in comparison to one-level cases and were associated with higher complication (11.9% vs. 27.6%; p=.03) and inferior satisfaction rates (p<.003).
Despite the fact that the current data comprises the early experiences and learning curve associated with a new surgical technique, the results demonstrate satisfactory and maintained mid- to long-term clinical results after a mean FU of 7.4 years. Patient safety was proven with acceptable complication and reoperation rates. Fear of excessive late complications or reoperations following the primary TDR procedure cannot be substantiated with the present data. In carefully selected cases, TDR can be considered a viable treatment alternative to lumbar fusion for which spine communities around the world seem to have accepted mediocre clinical results as well as obvious and significant drawbacks.
腰椎运动节段融合术在治疗无畸形或不稳定的退行性椎间盘疾病(DDD)所致顽固性下腰痛(LBP)中的作用仍存在争议。全腰椎间盘置换术(TDR)已被用于高度选择的患者队列。然而,TDR的长期随访(FU)数据量有限。在美国,保险公司因担心延迟并发症、翻修手术及未知的二次费用而拒绝为外科医生进行的TDR手术报销,导致TDR手术数量急剧下降。
评估TDR在围手术期并发症和再次手术率方面的中长期临床疗效及患者安全性。
研究设计/场所:对使用ProDisc II(美国宾夕法尼亚州波利市的Synthes公司)进行TDR治疗腰椎DDD所致LBP且经保守治疗无效的患者进行前瞻性单中心临床研究。
接受TDR治疗后至少随访5年的患者,该治疗用于治疗由DDD引起的顽固性且主要为轴向(≥80%)的LBP,无任何畸形或不稳定。
视觉模拟量表(VAS)、Oswestry功能障碍指数(ODI)及患者满意度评分(三级结果评定);并发症和再次手术率以及直至翻修手术的时间;患者的职业活动/就业状况。
临床结果评分是在一项正在进行的前瞻性临床试验框架内获取的。患者在术前、术后3个月、6个月和12个月进行检查,此后每年检查一次。数据采集由诊所脊柱科成员进行,包括未参与术前或术后决策过程的医务人员、研究助理和研究护士。
初始队列由201例患者组成;181例患者可进行最终随访,平均随访7.4年(范围5.0 - 10.8年)后随访率达90.0%。总体结果显示,在所有术后随访阶段,与基线VAS和ODI水平相比均有高度显著改善(p <.0001)。VAS评分从48个月起有轻微(从VAS 2.6降至3.3)但具有统计学意义的恶化(p <.05)。患者满意度在整个术后过程中保持稳定,63.6%的患者报告结果高度满意或满意(22.7%),而13.7%的患者不满意。总体并发症发生率为14.4%(N = 26/181)。因一般和/或与器械相关并发症进行翻修手术的发生率为7.2%(N = 13/181)。与基线水平相比,两节段TDR的VAS和ODI评分有显著改善(p <.05)。然而,与单节段病例相比,结果明显较差,且并发症发生率更高(11.9%对27.6%;p =.03),满意度较低(p <.003)。
尽管目前的数据包含了与一种新手术技术相关的早期经验和学习曲线,但结果表明在平均随访7.4年后,中长期临床结果令人满意且得以维持。并发症和再次手术率可接受,证明了患者安全性。目前的数据无法证实对初次TDR手术后过多晚期并发症或再次手术的担忧。在精心挑选的病例中,TDR可被视为腰椎融合术的一种可行替代方案,而全球脊柱学界似乎已接受了腰椎融合术一般的临床结果以及明显且重大的缺点。